Status and phase
Conditions
Treatments
About
This is a study to evaluate the response of patients with hypertension and early stage heart failure to valsartan.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Male or female 25-85 years of age, inclusive
Past diagnosis of hypertension for a min 1 year
Patients with an established treatment regimen for hypertension with one or more agents for a minimum period of 2 months
BP is considered adequately controlled with DBP < 90mmHg
Elevated BNP levels both in bedside test (62pg/ml) and after validation of a separate blood sample (40pg/ml) in the central laboratory
LV ejection fraction ³ 45%
LVH defined as myocardial mass ³ 116 g /m2 in males and 104 g/m2 in females
At least one of the following parameters of diastolic dysfunction
Exclusion criteria
• Present use of ACE inhibitor
Other protocol-defined exclusion criteria may apply.
Primary purpose
Allocation
Interventional model
Masking
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal